BioClinica

BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

Wednesday, May 5, 2010 01:07 PM

BioClinica’s first quarter 2010 earnings were flat compared with the same period 2009, with service revenues of $14.7 million. First quarter revenues last year were $14.5 million. Net income was $711,000, or $0.05 per diluted share, compared with $786,000, or $0.05 per diluted share for Q1 2009.

More... »

Oracle to Acquire Phase Forward for $685M

Friday, April 16, 2010 02:37 PM

Business software giant Oracle, already a player in the eClinical space, plans to acquire market leader Phase Forward in a deal valued at approximately $685 million—or $17 per share in cash.

More... »

BioClinica Buys TranSenda, Adds CTMS to Service Offerings

Monday, April 5, 2010 06:52 AM

BioClinica continued to grow its burgeoning eClinical division with the acquisition of clinical trial management software (CTMS) company TranSenda for an estimated $2.5 million.

More... »

BioClinica, Health Decisions Broaden CRO Networks

Thursday, March 18, 2010 07:42 AM

BioClinica added two contract research organizations (CROs)—Health Sciences International and PRL Central Laboratory Services—to its Certified Partner Program, a group established by the CRO to broaden its service offerings. 

More... »

BioClinica Revenues Flat in ‘09

Thursday, February 11, 2010 06:28 AM

BioClinica reported its fourth quarter and full-year 2009 earnings earlier this week. Service revenues for the quarter were almost flat from the fourth quarter 2008 at $14.9 million. Income from continuing operations was $943,000, or $0.06 per fully diluted share, compared with income of $1.7 million for the same period 2008.

More... »

BioClinica Buys Tourtellotte Solutions for $2.1M

Thursday, September 17, 2009 06:30 AM

BioClinica’s September buying spree continued this week with the announcement that the Newtown, Pa.-based contract research organization (CRO) had purchased technology company Tourtellotte Solutions for $2.1 million in cash, plus additional payments in the form of up to $3.2 million in cash and 350,000 shares of BioClinica common stock if certain milestones are met.

More... »

BioClinica Acquires CardioNow

Tuesday, September 8, 2009 06:21 AM

Newtown, Pa.-based contract research organization (CRO) BioClinica is continuing its efforts toward becoming a clinical trial technology “super brand” with its recent acquisition of the CardioNow unit of Agfa Healthcare.

More... »

BioClinica Profits Fall 50%, Continues to Seek Acquisitions

Wednesday, August 5, 2009 06:58 AM

BioClinica’s revenues and profits continued to fall in the second quarter, with net income sliced by half from the same period in 2008 to $529,000. Diluted earnings per share were $0.04 compared with $0.10 in the second quarter 2008. Revenues for the Newtown, Pa.-based contract research organization (CRO) also dropped 11% to $17.1 million.

More... »

Etrials Pays $500K to Terminate Agreement with BioClinica

Wednesday, June 3, 2009 07:00 AM

Only days after BioClinica increased its purchase offer to acquire etrials Worldwide and the two companies agreed to proceed with their acquisition agreement, that agreement has been terminated.

More... »

BioClinica Increases Offer to Buy etrials Worldwide

Thursday, May 21, 2009 08:30 AM

BioClinica, formerly Bio-Imaging Technologies, increased the value of its offer to acquire troubled eClinical vendor etrials Worldwide in response to an unsolicited offer received by etrials from an unrelated third party.

More... »